H31.123 Diffuse secondary atrophy of choroid, bilateral

Name of the Condition

• Diffuse secondary atrophy of choroid, bilateral (ICD Code: H31.123)

Summary

Diffuse secondary atrophy of the choroid, bilateral, is a condition characterized by widespread degeneration and thinning of the choroidal tissue in both eyes, resulting from an underlying cause. This process can lead to structural changes in choroidal tissue, potentially impacting retinal health and visual function depending on the extent and location of the atrophy.

Causes

Diffuse secondary atrophy of the choroid typically results from systemic diseases, chronic inflammation, or vascular insufficiency affecting ocular blood flow. Common underlying causes include hypertension, atherosclerosis, autoimmune disorders, or long-term exposure to certain environmental factors. In some cases, it may be associated with infections or neoplastic processes.

Risk Factors

• Advanced age
• Systemic vascular diseases (e.g., hypertension, atherosclerosis)
• Chronic ocular inflammation or infection
• Autoimmune disorders
• Prolonged exposure to ultraviolet light
• Genetic predispositions

Symptoms

• Gradual loss of peripheral or central vision in both eyes
• Blurred or distorted vision in both eyes
• Difficulty adapting to low light conditions in both eyes
• Visual field defects in both eyes
• Reduced visual acuity in advanced cases

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated fundus evaluation, optical coherence tomography (OCT), and fluorescein angiography to assess choroidal structure and function. Imaging studies help identify the extent of atrophy and rule out other ocular conditions. A thorough medical history and systemic evaluation may be necessary to determine underlying causes.

Treatment Options

Treatment focuses on addressing the underlying cause and managing symptoms. This may include controlling systemic conditions (e.g., hypertension, autoimmune disorders), anti-inflammatory medications, or vascular therapies. Low vision aids and rehabilitation may be recommended to support visual function. Regular monitoring is essential to track disease progression.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and the extent of choroidal damage. Early intervention and management of contributing factors can help slow progression. Follow-up care typically involves regular eye examinations to monitor visual function and adjust treatment as needed. Long-term outcomes vary based on individual circumstances.

Complications

Potential complications include progressive vision loss, retinal degeneration, and impaired visual function. In severe cases, irreversible damage to the retina or optic nerve may occur, leading to permanent visual impairment. Prompt management of underlying conditions is critical to minimize risks.

Lifestyle & Prevention

Maintaining overall health through regular exercise, a balanced diet, and blood pressure control may help reduce risk. Protecting eyes from excessive UV exposure and managing systemic diseases can support ocular health. Routine eye exams are recommended for early detection of changes.

When to Seek Professional Help

Seek medical attention if you experience persistent vision changes, blurred or distorted vision, or difficulty seeing in low light. Prompt evaluation is important to identify and address underlying causes and prevent further damage.

Tips for Medical Coders

When coding H31.123, ensure documentation specifies bilateral involvement and confirms the condition as secondary (i.e., resulting from an underlying cause). Include details about the extent of atrophy and any associated symptoms or findings to support accurate coding. Verify that the diagnosis aligns with clinical criteria and that no conflicting conditions are present.